Synergistic potential of combined tocotrienols-astaxanthin in addressing inflammation caused by IL-1β induced in A549 cell lines

Abstract

NSAIDs are commonly used to treat inflammatory diseases but are associated with adverse side effects. The combination of astaxanthin and tocotrienols has been found to have anti-inflammatory and antioxidant properties in reducing inflammation.